Skip to main content
Premium Trial:

Request an Annual Quote

Stratagene Refutes Third Wave s Patent-Infringement Lawsuit Over PCR Reagents

Stratagene said last week that a patent infringement lawsuit Third Wave filed against it on Wednesday is without merit.

“We are surprised that Third Wave would file this lawsuit before discussing with us the differences in the two companies’ technologies,” said Joseph Sorge, Stratagene’s chairman and CEO.

The patent infringement suit filed in US District Court in Madison, Wis., seeks a permanent injunction against Stratagene that would prevent the sale of the company’s probe-based quantitative PCR and RT-PCR reagents. It claims that Stratagene violates some of the more than 30 patents that protect Third Wave’s Invader products, which use invasive cleavage structure chemistry to analyze nucleic acids and infectious agents, as does Stratagene’s FullVelocity product line.

Third Wave previously won a similar suit filed against EraGen Biosciences of Madison, Wis. The suit was settled in the same US District Court and resulted in EraGen removing the products in question from the market.

Stratagene’s CEO said his company’s patents in the area of cleavage chemistry cover technologies that differ from Third Wave’s patented technologies.

“Stratagene does not include overlapping DNA molecules in its kits,” said Sorge. “In contrast, Stratagene’s Full Velocity technology benefits from the sensitivity advantages of PCR amplification, something not found in Third Wave’s Invader methods.”

Invader products account for most of Third Wave’s total revenue. For Stratagene, real-time PCR accounts for roughly 25 percent of Stratagene’s revenue; around 5 percent of that comes from RT-PCR reagents. FullVelocity products make up a fraction of the firm’s RT-PCR reagents.

— Mo Krochmal ([email protected]) Chris Womack of Pharmacogenomics Reporter contributed to this report.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.